People and Business News — 5/22
People News
Rho has appointed Peter Schmidt, PhD, as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division.
Syneos Health announced the promotions of Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs.
Cytel Inc. has appointed Albert Kim, PhD, as its first Chief Medical Officer.
Greater Gift announces new board members, Clare Grace, Sharon Hanlon and Harsha Rajasimha.
HeartcoR Solutions announced that Dennis Bergau has joined the company as Vice President of Clinical Operations.
PHASTAR announced Ping-Chung Chang has joined the company as Head of China Development and Global Delivery.
Syneos Health announced the appointment of Michelle Keefe as CEO and a member of the Company’s Board of Directors.
Worldwide Clinical Trials announced Rosemarie Corrigan has joined the company as executive vice president, global quality.
physIQ announced the appointment of two new members to its executive leadership team. John Wilson has been named Senior Vice President and General Manager of Life Sciences, and Chris Englerth joins the team as Vice President of Marketing.
Business News
ActiGraph is the latest business to receive funding through the Industry Resilience and Diversification Fund.
Clinerion has received patent protection for their revolutionary ANID technology.
Emmes announced that it is providing data, statistical analysis, and project management support for new research that will test the Moderna mRNA vaccine at more than 50 sites in South and East Africa.
Clario announced the release of its first Environmental, Social and Governance Report.
Recognition
Northwestern University Feinberg School of Medicine Research Team:Robert F. Kushner, MD, Alicia Agnoli, MD, MPH, MHS, Lesley Inker, MD, and Chi-yuan Hsu, MD, MS
The Herbert Pardes Clinical Research Excellence Award, was given to a research team from Northwestern University Feinberg School of Medicine the study, Once-Weekly Semaglutide in Adults with Overweight or Obesity. Two additional Distinguished Clinical Research Achievement Awards (one shared) were presented for their creativity, innovation, and novel approach that demonstrated immediate impact on the health and well-being of patients to University of California, Davis and to Tufts University School of Medicine andUniversity of California San Francisco.
Rho was named the winner of a Silver Stevie Award in the Fastest Growing Company of the Year category in the 20th Annual American Business Awards.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
